Healthcare Sector

India's single-specialty healthcare market to triple to over $12 bn by 2030

Report points to a structural shift in India's $54 billion healthcare market as focused, asset-light providers scale alongside large hospitals

Budget 2026: Biopharma to medical tourism, push for healthcare value chain

Union Budget 2026 proposes measures across biopharma manufacturing, medical education, research, affordable drugs, AYUSH and medical tourism, signalling a deeper healthcare strategy

Budget 2026: Govt to set up 5 medical tourism hubs, train 150K caregivers

Finance Minister Nirmala Sitharaman announced measures in the Union Budget 2026-27 to boost medical tourism, including support for five regional hubs in partnership with states and the private sector

Nivaan Care raises $7 million to expand pain management clinics in India

Series A round led by Sorin Investments backs the rollout of minimally invasive, single specialty centres

Australia can rein in health spending with stronger focus on prevention

Australia's spending on health and social care is growing as a share of the economy and now makes up five of the top seven fiscal pressures facing the federal budget

HDFC Sec turns bullish on Dr Lal PathLabs; upgrades to 'Buy'; raises target

Dr Lal PathLabs is focusing on innovation, including new wellness packages and high-end, super-speciality tests, with a focus on capturing prescription shares

Healthcare IPO count jumps in 2025; fundraising flat, returns soften

The surge has come alongside a decline in average issue sizes and more muted listing-day returns compared with last year

Year-ender 2025: Financials, new-age cos dominate India's IPO fundraising

Financial services accounted for the largest share of IPO issuance in 2025, reflecting strong issuance from NBFCs, asset managers, insurers and financial platforms during the year

Fortis Healthcare gains on Bengaluru expansion; JM Financial upgrades stock

JM Financial has set a target price of ₹1,093 on Fortis Healthcare stock, a potential upside of 22.7 per cent from Friday's closing price

Gujarat Kidney IPO: Fair valuations, analysts cautious; should you bid?

The three-day subscription window to bid for the Gujarat Kidney IPO will close on Wednesday, December 24, 2025

Investing in Gujarat Kidney IPO? Check 5 key risks before you decide

Gujarat Kidney IPO will be offered at a price band of ₹108 to ₹114 per share, with a lot size of 128 shares

Motilal Oswal initiates IKS, Sagility with 'Buy'; Indegene 'Neutral'

The US remains the world's most lucrative outsourcing market, with healthcare spending touching nearly $5 trillion in CY24, accounting for 17-18 per cent of GDP.

Health care sector welcomes Bill that taxes pan masala production

Industry says earmarking funds for public health at par with national security will help channel revenue for public health infra

Thyrocare Tech up 137% in FY26, to give 2 bonus shares; check details here

Thyrocare Technologies board had fixed November 28 as the record date for its 2:1 bonus share issue. This smallcap stock has gained 40 per cent in the last two months.

Policymakers-industry partnership vital for healthcare delivery: Dr Reddy's

Dr Reddy's Laboratories on Monday said partnerships between policymakers and industry are vital to build a future-ready healthcare system that serves millions. Satish Reddy, the chairman of the Hyderabad-based drug major, joined industry leaders at the sixth Pre-Budget Consultation chaired by Union Finance Minister Nirmala Sitharaman in the national capital. He shared his perspective on the importance of risk-based innovation funding to strengthen India's pharmaceutical ecosystem and accelerate breakthroughs that improve patient access and affordability. "At Dr Reddy's, we believe that partnerships between policymakers and industry are vital to building a future-ready healthcare system that serves millions," Reddy said in a post shared by the drug firm on social networking platform LinkedIn.

Max Healthcare shares rise 2% after Q2 results; JM Fin upgrades rating

JM Financial upgraded the stock to an 'Add' rating after the company reported a 74 per cent jump in its September quarter net profit

Narayana acquires UK-based Practice Plus Group Hospitals for ₹2,200 crore

The deal marks the Indian hospital chain's entry into the British healthcare market, strengthening its ambition to expand globally

Govt to bring law for strict quality checks, monitoring of drugs, cosmetics

Amid growing demand for stricter compliance with safety and quality control norms for medical products, the Centre is framing a law to strengthen the legal framework for drug quality testing and market surveillance, along with regulation of medical devices and cosmetics. One of the major reasons behind the drafting of the law is the repeated complaints and concerns flagged by health regulators across the globe, including the WHO, over serious quality lapses by Indian drug manufacturers. The draft of the 'Drugs, Medical Devices and Cosmetics Act 2025', which the government aims to introduce in the upcoming Winter session of Parliament, was presented by Drugs Controller General of India (DCGI) Dr Rajeev Raghuvanshi at a high-level meeting of the Union health ministry held on Tuesday, the sources said. The meeting was chaired by Union Health Minister J P Nadda. During the meeting, senior officials from the Drugs Controller General of India (DCGI) and the Central Drugs Standard Control

Healthcare industry welcomes faster GST refunds, seeks broader reform

The Central Board of Indirect Taxes and Customs (CBIC) recently announced that 90 per cent of GST refunds will now be released upfront for low-risk taxpayers

Drug regulator begins pan-Indian inspection of cough syrup makers

The regulator has sought a list of cough syrup manufacturers from all states and UTs following reports of toxic contaminants linked to child deaths in Madhya Pradesh